On January 2, 2019 Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led biopharmaceutical company committed to identifying, developing, and commercializing innovative therapies to address significant unmet needs in dermatology and immunology, reported that management will attend the following conferences (Press release, Aclaris Therapeutics, JAN 2, 2019, View Source [SID1234532335]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Management will host investor meetings during the 2019 JP Morgan Healthcare Conference in San Francisco, CA from Monday, January 7, 2019 through Wednesday, January 9, 2019.

Dr. Neal Walker, President and Chief Executive Officer, will present at the 8th Annual Leerink Partners Global Healthcare Conference in New York, NY on Wednesday, February 27, 2019 at 10:30 AM EST. Management will also host investor meetings on Wednesday, February 27, 2019.
A live webcast of the 8th Annual Leerink Partners Global Healthcare Conference presentation may be accessed through the Company’s web site, www.aclaristx.com, on the ‘Events and Presentations’ section. An archived version of the presentation will be available for 30 days.